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In the present study, we conducted microarray gene expression profiling to explore
the direction of differentiation of human amnion epithelial cells (hAECs) treated with
rosmarinic acid (RA). hAECs have several clinical advantages over other types of stem
cells, including availability, low immunogenicity, low rejection rate, non-tumorigenicity,
and less ethical constraint. On the other hand, RA is a phenolic compound having
several health benefits, including neuroprotective and antidepressant-like activities. In
this study, hAECs were isolated from discarded term placenta and were treated with
20 µM RA for 7 days. Microarray gene expression profiling was conducted for three
biological replicates of RA-treated and untreated control cells on day 0 and day
7. Gene set enrichment analysis, and gene annotation and pathway analysis were
conducted using online data mining tools GSEA and DAVID. Gene expression profiling
showed that RA treatment biased hAECs toward ectodermal lineage progression,
regulated transcription factors involved in neuronal differentiation, regulated neural
specific epigenetic modifiers and several extracellular signaling pathways of neural
induction, and significantly inhibited Notch signaling pathway. Gene expression profiling
of RA-treated hAECs reveals for the first time a potential role of RA in neural induction
and neuronal differentiation of hAECs. Having a naturally occurring compound as
differentiation inducer as well as a readily available source of stem cells would have
great advantages for the cell-based therapies. Findings from our genome-wide analysis
could provide a foundation for further in-depth investigation.
Keywords: human amnion epithelial cell, rosmarinic acid, microarray analysis, system biology, neural induction,
neuronal differentiation, natural compound
Abbreviations: bHLH, basic helix-loop-helix; cRNA, complementary RNA; DEGs, differentially expressed genes; EMT,
epithelial-mesenchymal transition; ESCs, embryonic stem cells; GAD, genetic association database; GO, gene ontology;
hAECs, human amnion epithelial cells; HDAC, histone deacetylase; iPSCs, induced PSCs; MSCs, mesenchymal stem cells;
PRC, polycomb repressive complex; PSCs, pluripotent stem cells; RA, rosmarinic acid.
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INTRODUCTION
Human amnion epithelial cell is gaining interest as a novel
alternative source of stem cells in the field of regenerative cellular
therapy. hAECs express surface markers of both ESCs and MSCs
and have similar functional properties of both of the stem
cells. Additionally, hAECs have several advantages over other
types of stem cells. Because of their embryonic origin, hAECs
retain their pluripotent potential and can be differentiated into
all three germ layers under proper condition. However, unlike
other stem cells, they do not form teratomas in vivo. Most
importantly, hAECs have low immunogenicity and a wide range
of immunomodulatory properties. These cells can be obtained
from discarded term placenta and are, therefore, readily available
and devoid of any ethical constraint. These unique properties
of hAECS offer significant practical advantages for potential
clinical applications (Miki et al., 2005; Miki and Strom, 2006;
De Coppi et al., 2007). In several studies, hAECS were induced
to differentiate into specific cell types, including hepatocytes,
adipocytes, myocytes, cardiomyocytes, osteocytes, pancreatic
cells, as well as neural and glial cells. However, it was reported
that hAECs are primarily committed to ectodermal lineage, and
can express several neural markers even before the induction of
differentiation (Pan et al., 2006). Treatment with retinoic acid
and basic fibroblast growth factor was also reported to induce
neural markers expression in hAECs (Niknejad et al., 2010).
Sakuragawa et al. (1996) reported that under certain conditions,
differentiated hAESCs can synthesize and release acetylcholine,
catecholamines, dopamine, neurotrophic factors, and noggin.
Use of hAECs in cellular therapies of spinal cord injuries has been
reported promising because of their ability to induce neuronal
differentiation and neurotransmitter secretion. Thus, hAECs
have new therapeutic potential for several neurodegenerative
disorders that affect the central nervous system (McDonald et al.,
2011; Miki, 2011).
Currently, different synthetic and semi-biological cytokines,
recombinant growth factors, and proteins are used for stem
cell proliferation and differentiation. Most of these substances
have several drawbacks. They may show toxic effects, have a
possible risk of rejection, and can cause malignancy (Marion and
Mao, 2006; Raghavan et al., 2015). These reagents are rapidly
degradable and are required to replace continuously, making the
whole procedure highly expensive, hence limiting their use in
therapeutic tissue engineering. Therefore, a new research stream
has been evolving to use natural medicinal plant extracts as
stimulants of stem cells because of their high availability, low
toxicity, and minimum side effects (Raghavan et al., 2015). Plant-
derived extracts are rich in polyphenols, and flavonoids, and
have proven health beneficial effects. A few studies have reported
the differentiation potential of some herbal extracts on different
types of stem cells (Udalamaththa et al., 2016). Additionally,
several plant extracts and their active components showed
potential effects in neuronal differentiation and proliferation,
like phytochemicals from Butea superba in stem cells (Arai
et al., 2013), flavonoid component from Scutellaria baicalensis
in C17.2 cells (Li et al., 2012), acetic acid extract of Mucuna
gigantea in bone marrow-derived hMSCs (Kongros et al., 2012),
Salvia miltiorrhiza extract on Wharton jelly derived hMSCs
(Ma et al., 2005). However, to our knowledge, there is no
study to date reporting the effect of any natural compounds on
hAECs differentiation.
As a part of our continued research efforts to explore
beneficial effects of naturally occurring compounds of plant
origin from the Mediterranean region, we have been investigating
the effects of different natural compounds on the direction of
hAECs differentiation. Rosmarinic acid is a phenolic compound
and an ester of caffeic acid. It is commonly found in several
culinary herb species, like Rosmarinus officinalis (rosemary),
Ocimum basilicum (basil), Ocimum tenuiflorum (holy basil), and
Melissa officinalis (lemon balm). It has several health benefits,
like anti-inflammatory, antioxidative, and neuroprotective effects
(Alagawany et al., 2017). We have previously reported that
ethanolic extract of R. officinalis, as well as RA itself, has
neuroprotective and anti-depressant like activities both in vitro
and in vivo (Sasaki et al., 2013; Kondo et al., 2015). We
also reported neuronal cell differentiation induction effects of
essential oil of R. officinalis (Villareal et al., 2017).
Microarray gene expression profiling is a useful tool to
explore genome-wide expression patterns that are activated
during studied biological conditions and provides a foundation
for further examination of molecular mechanism and regulatory
pathways. In this study, we treated three dimensional (3D)
spheroids of hAEC with 20 µM of RA for 7 days and conducted
microarray analysis to explore its effects on the direction of
hAECs differentiation.
MATERIALS AND METHODS
Extraction of Amnion Epithelial Cells
Amnion epithelial cells were isolated from delivered term
placenta. The amnion was aseptically separated from the chorion
and was washed with 200 mL of Hank’s Basic Salt Solution –
Calcium and Magnesium Free (CMF-HBSS) to remove blot clots
on the membrane. The amnion was then cut into smaller pieces
using surgical scissors and placed into 50 mL conical tubes. A pre-
digestion buffer (CMF-HBSS, 0.5 mM EGTA, 20 mL) was added
to the tubes. The amnion was gently rocked in the solution for
30 s and was transferred to new 50 mL conical tubes. Twenty
mL of pre-digestion buffer was added to the amnion tissue and
was incubated at 37◦C for 10 min. The pre-digestion buffer
was discarded and 20 mL of 0.05% trypsin-EDTA was added to
the tissue. The tubes were incubated for 40 min at 37◦C and
then placed on ice after incubation. Two volumes of Dulbecco’s
Modified Eagle Medium (DMEM, 10% FBS, 1% Penn-Strep)
was added to the trypsin digest and centrifuged at 200 g for
10 min at 4◦C. The supernatant was discarded and the pellet was
resuspended in 10 mL of DMEM. Small tissue aggregates were
removed by filtration through a 100µm filter. The cell suspension
was collected and the membrane was discarded.
Cell Culture Maintenance
Amnion epithelial cells were maintained in Placenta Epithelial
Cell Basal Medium (PromoCell, Cat. #C-26140). Cells were
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constantly monitored with media change every 2–4 days. To
subculture AECs, the plates were first washed twice with 10 mL
of PBS. The PBS was discarded and 3 mL of pre-digestion buffer
(pre-warmed to 37◦C) was added to the plate. The plate was
incubated at 37◦C for 5 min. Five mL of 0.05% (w/v) trypsin-
EDTA (pre-warmed to 37◦C) was then added to the plate and
incubated at 37◦C for 10 min. Five mL of DMEM was added to
stop the reaction. The cell suspension was placed into conical
tubes and centrifuged at 200 RPM for 4 min at 4◦C. The
supernatant was discarded and the pellet was resuspended in
DMEM. The cell suspension was again centrifuged at 200 RPM
for 4 min at 4◦C. The supernatant was discarded and the cells
were resuspended in the placental cell medium. The cells were
then seeded onto new cell culture dishes.
Preparation of 3D Culture Plates
Lipidure TM (NOF Corporation, Cat. #CMS206; 400 µL)
solution (50 mg in 10 mL absolute ethanol) was placed into each
well of the 3D culture plate (ElplasiaTM, Kuraray Co., Ltd., Cat
#RB 500 400 NA 24) and was allowed to sit for 2 min. The
Lipidure TM solution was aspirated out and the plate was dried
for 3 h. After drying, 400 µL of PBS was placed in each well
and the plate was centrifuged at 2000 g for 15 min at room
temperature. The plate was observed under the microscope to
ensure that there were no bubbles in the wells. The PBS was then
discarded and the wells were washed twice with 400 µL of PBS.
The plates were then stored in the cell culture incubator until use.
Spheroid Formation and Compound
Supplement
From each well of the 3D culture plate, 300 µL of PBS was
aspirated. Spheroids were formed by seeding 1 × 106 AECs
in Placenta Basal Epithelial Cell Medium into each well of the
24-well plate. After the initial 24 h culture, the medium was
changed with 20 µM of RA (FUJIFILM Wako Pure Chemical
Corporation, Japan) every 48 h for three times for the treatment
samples. Day 0 control (D0) samples were collected before adding
the treatment to the cells. Control samples were maintained in
the Placental medium that was also changed every 48 h. Finally,
we collected the treatment (T7) and control (D7) samples from 1-
week culture.
RNA Extraction and Quantification
For RNA extraction, Isogen (Nippon Gene Co., Ltd., Toyama,
Japan) was added and the cell suspensions were centrifuged
for 5 min at 500 g and the pellet was stored at −80◦C until
use. The integrity of RNA was quantified using NanoDrop
2000 spectrophotometer (Thermo Fisher Scientific, Wilmington,
DE, United States).
Microarray Expression and Data Analysis
We prepared RNA samples for gene expression profiling analysis
with GeneChip R© 3′ Expression Arrays using 3′ IVT PLUS Reagent
Kit (Affymetrix Inc., Santa Clara, CA, United States). Two
hundred and fifty ng of total RNA from each sample was used to
generate amplified and biotinylated cRNA from poly (A) RNA in
a total RNA sample according to the user manual. IVT Incubation
time was 16 h. GeneAtlas R© Hybridization, Wash and Stain Kit
was used for hybridizing 3′ IVT Array Strips according to the
user manual (P/N 08-0306). Human genome array strips (HG-
U219) were hybridized for 16 h in a 45◦C incubator, washed
and stained and finally imaging was done with the GeneAtlas
Fluidics and Imaging Station. HG 219 array strip can determine
the expression profile of 49386 genes. Microarray expression
profiling was conducted for two biological replicates between
T7 and D0 samples and three biological replicates between
T7 and D7 samples.
The raw data were normalized using Expression Console
Software provided by the Affymetrix following robust multichip
average (RMA) algorithm1. Subsequent analysis of the gene
expression data was carried out in the freely available
Transcriptome Analysis Console (TAC) version 4 (Thermo
Fisher Scientific Inc.). Genes with a fold change > 1.1 (in linear
space) and p-Value < 0.05 (one-way between-subject) were
considered as DEGs. Further analysis was conducted using
an online data mining tool DAVID (Database for Annotation,
Visualization, and Integrated Discovery, version 6.8). We
used “Functional Annotation” tool of DAVID to identify the
most relevant biological terms, including GO terms, biological
pathways, tissue expression, and disease associations (Huang da
et al., 2009). We also performed gene set enrichment analysis
(GSEA) for the top 3000 DEGs between T7 and D0 hAECs and
for all DEGs between T7 and D7 hAECs to test whether a priori-
defined groups of genes associated with neural differentiation
were significantly related to the DEGs between RA-treated and
control cells on day 0 and day 72 (Subramanian et al., 2005).
Ethics Approval
The protocol was reviewed and approved by the Ethical Review
Committee of the University of Tsukuba. Informed written
consent was obtained from the mothers who donated the
placenta after delivery.
RESULTS
We treated 3D hAECs with 20µM of RA for 7 days and compared
the gene expression pattern between untreated control cells on
day 0 and day 7 and RA-treated cells. We identified DEGs,
respectively, in two (T7 vs. D0) and three (T7 vs. D7) biological
replicates and explored the biological events that took place
during seven days of RA treatment.
Characteristics of AECs and DEGs
Several stem cell markers were expressed highly in the
undifferentiated hAECs, like SSEA-4 (99.2%), Tra-1-60 (71.1%),
Tra-1-81 (13.7%), EPCAM (75.4%), E-cadherin (99.9%), and
Lectin (98.1%) (Supplementary Figure 1). Additionally, AEC
spheroids (3D culture) highly expressed the stemness-related
genes compared to the 2D counterpart. On the 7th day
1http://www.affymetrix.com
2http://software.broadinstitute.org/gsea/index.jsp
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FIGURE 1 | Volcano plot displaying DEGs between (A) RA-treated (T7) and day 0 untreated-control (D0) hAECs, and (B) RA-treated (T7) and day 7
untreated-control (D7) hAECs. The vertical axis (y-axis) corresponds to -log10 p-Value of the ANOVA p-Values, and the horizontal axis (x-axis) displays linear fold
change. The red dots represent the up-regulated genes; the green dots represent the downregulated genes. Pie chart showing the enriched (p < 0.05) tissue
expressions by the DEGs between (C) RA-treated (T7) and day 0 untreated-control (D0) hAECs, and (D) RA-treated (T7) and day 7 untreated-control (D7) hAECs.
Venn diagram showing common and unique sets of DEGs between each exposure. Blue circles denote DEGs between RA-treated (T7) and day 0 untreated-control
(D0), red circles denote DEGs between RA-treated (T7) and day 7 untreated-control (D7). (E) Venn diagram for upregulated DEGs. (F) Venn diagram for
downregulated DEGs. Significantly enriched gene ontology (GO) have been listed for each set of DEGs.
of culture, 3D spheroids expressed OCT-4, NANOG, LIN28,
SOX-2, C-MYC, and KLF4 significantly higher than 2D cells
(Supplementary Figure 2).
Although a huge number of genes were differentially expressed
between treatment and control cells on day 0 (T7 vs. D0), there
was not much change in gene expression between treatment and
control cells on day 7 (T7 vs. D7), as we did not add any additional
supplements to induce differentiation (Supplementary Figure 3).
To understand the integrative response of hAECs, including how
they actively adjust transcriptome after RA treatment through
GO annotation groups, we assigned the cutoff for DEGs to
be >1.1 (fold change); p-Value < 0.05. We found 23 976
genes between T7 and D0 samples and 1740 genes between
T7 and D7 samples were consistently differentially expressed.
After deleting duplicates and unnamed genes, we identified
13 396 DEGs between T7 and D0 samples, among which 11
930 genes were upregulated and 1466 were downregulated.
On the other hand, there were 1572 DEGs between T7
and D7 samples, among which 176 genes were upregulated
and 1396 genes were downregulated. Volcano plots show the
distribution of fold change and significance levels of the DEGs
(Figures 1A,B). We found that nearly 60% of DEGs were brain-
specific (Figures 1C,D). We assumed RA treatment could induce,
at least in part, neuronal differentiation.
Significantly Enriched Gene Sets and GO
Gene set enrichment analysis showed that several priori-
defined hallmark gene sets associated with cell cycle, such
as G2/M checkpoint and E2F targets, along with GO of
cell differentiation (GO: 0045595) and neurogenesis (GO:
0022008) were significantly enriched by the DEGs between
T7 and D0 cells (Table 1). When compared between T7 and
D7 cells, significantly enriched GO were cell differentiation
(GO: 0045595), neurogenesis (GO: 0022008), and neuron
differentiation (GO: 0030182). Top gene sets by the unique
upregulated DEGs between T7 and D0 were nucleic acid binding
(GO: 0001071), metal ion binding (GO: 0046914), and Zinc ion
binding (GO: 0008270); while top significantly enriched gene
sets by the unique upregulated DEGs between T7 and D7 were
RNA binding (GO: 0003723), enzyme binding (GO: 0019899),
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TABLE 1 | Significantly enriched gene sets by DEGs between RA treated and control cells.
Gene Set Name∗ Systematic name,
exact source
No. of genes in
set
No. of genes in
overlap
p-value Adjusted
p-value
Significantly enriched gene sets by DEGs between RA treated (T7) and control cells (D0)
HALLMARK1_G2M_CHECKPOINT2 200 81 2.56 e−46 1.28 e−44
HALLMARK_E2F_TARGETS3 200 70 2.38 e−35 5.94 e−34
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION 200 58 1.01 e−24 1.01 e−23
GO_CELL_CYCLE M14460,
GO:0007049
1316 284 5.72 e−84 3.39 e−80
GO_CYTOSKELETON M17350,
GO:0005856
1967 351 2.33 e−80 6.95 e−77
GO_REGULATION_OF_CELL_DIFFERENTIATION M13423,
GO:0045595
1492 236 3.55 e−44 5.88 e−42
GO_NEUROGENESIS M13908,
GO:0022008
1402 206 6.57 e−34 5.05 e−32
Significantly enriched gene sets by DEGs between RA treated (T7) and control cells (D7)
GO_NEUROLOGICAL_SYSTEM_PROCESS M10152,
GO:0050877
1242 133 3.36 e−35 1.71 e−32
GO_NEUROGENESIS M13908,
GO:0022008
1402 141 2.47 e−34 1.09 e−31
GO_REGULATION_OF_CELL_DIFFERENTIATION M13423,
GO:0045595
1492 142 5.11 e−32 1.8 e−29
GO_NEURON_DIFFERENTIATION M15330,
GO:0030182
874 92 4.8 e−24 6.81 e−22
∗GSEA online software (http://software.broadinstitute.org/gsea/index.jsp). 1Hallmark gene sets summarize and represent specific well-defined biological states or
processes and display coherent expression. 2Genes involved in the G2/M checkpoint, as in progression through the cell division cycle. 3Genes encoding cell cycle
related targets of E2F transcription factors.
and neuron part (GO: 0097458; Figure 1E). Figure 1F shows
the top significantly enriched gene sets by the unique sets of
downregulated DEGs between each exposure. Detailed functional
analysis of DEGs between T7 and D0 and between T7 and D7 is
presented in Figure 2 and Supplementary Figure 4, respectively.
Supplementary Table 1 listed the fold changes and p-Values
of important DEGs. Top ten upregulated DEGs between T7
and D0 are significantly associated with tissue development
(GO: 0009888, p = 2.41 e−7) and epithelial cell differentiation
(GO: 0030855, p = 2.65 e−6).
RA Treatment Biased hAECs Toward
Ectodermal Lineage Progression
In the RA-treated cells, there was no expression of stem cell
marker genes, indicating that the cells lost their stemness and
proceeded toward differentiation. Several endoderm marker
genes, like GATA1, HNF4A, NKX3, and SOX17 were significantly
upregulated when compared between T7 vs. D0 cells, whereas
significantly downregulated when compared between T7 and D7
(Supplementary Table 1). Similarly, some mesoderm marker
genes, namely MEST, MEOX1, MESDC1, DLL3, MESP1, and
FOXF1 were also downregulated when compared between T7
and D7. The expression of some known ectoderm marker genes,
including OTX, SOX1, and PAX6, were significantly upregulated
when compared between T7 and D0 hAECs, but no change in
expression was observed when compared between T7 and D7
hAECs. However, a less well-known early ectoderm development
marker gene EED was expressed significantly higher in both
exposures (1.64 and 1.73 fold in T7 vs. D0 and T7 vs. D7,
respectively). Eed is a polycomb protein and a core protein of
PRC 2. It is expressed by neural stem cells (NSCs) and is necessary
for subventricular zone NSC activation, and neurogenesis (Sun
et al., 2018). When compared between T7 and D7 hAECs,
GSEA showed that 91 DEGs matched the set “PRC2 targets” (p-
Value = 6.47 e−33), and 119 DEGs matched the set “Eed targets”
(p-Value = 2.17 e−33) identified in human ESCs (Ben-Porath
et al., 2008). There was upregulation of BCOR (1.28 fold), a
transcriptional corepressor of BCL6 (Huynh et al., 2000). Bcl6
controls neurogenesis through epigenetic repression of selective
Notch targets. There was downregulation of DPPA4 (1.32 fold), a
possible inhibitor of embryonic cell differentiation into primitive
ectoderm lineage.
RA Treatment Regulated TFs Involved in
Neuronal Differentiation
Analysis of up- and downregulated TFs between T7 vs. D7 hAECs
revealed TFs involved in neuronal differentiation were highly
regulated (TCF12, HNRNPD, NLK, and SMAD5). Tcf12 (also
known as HEB in human) is a member of bHLH E-proteins
that are heterodimeric partners of neural-specific bHLH proteins
(Uittenbogaard and Chiaramello, 2002; Mesman and Smidt,
2017). Tcf12 plays an important role both in the early cell-fate
commitment of neural progenitors and in subset specification.
On the other hand, HELT, a bHLH transcriptional repressor
of neuronal differentiation, was downregulated (Nakatani et al.,
2004). Nlk is a positive effector of the non-canonical Wnt
pathway and enhances neural fate by limiting epidermal choice.
Additionally, Smad5 activity is reported to be important for the
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FIGURE 2 | Functional analysis of DEGs between RA-treated (T7) and day 7 untreated control (D7) hAECs. (A) Changes in the expression of epigenetic modifiers by
RA treatment (T7) compared with untreated-control on day 7 (D7); (B) Significantly enriched cellular components (p < 0.05; modified Fisher’s exact test); (C) Top
molecular functions as per p-Value (modified Fisher’s exact) by downregulated genes. (D) Top molecular functions as per p-Value (modified Fisher’s exact) by
upregulated genes. (E) Significantly enriched KEGG pathways by downregulated genes (p < 0.05; modified Fisher’s exact test). (F) Significantly enriched
psychological and neurological diseases (p < 0.05; modified Fisher’s exact test).
maintenance of neural progenitor cells. Loss of Smad 5 along with
Smad 1 could reduce the number of newly generated neurons
and forced cell cycle exit and premature neurogenesis of neural
progenitors. On the other hand, ASCL1 that plays a role at
early stages of development of specific neural lineages probably
through DLL4-NOTCH signaling activation was downregulated.
Several TFs involved in epidermal differentiation (TCF7L1),
epithelial cell growth (FOXE3 and EHF), lymphocyte
development (ZBTB17), lymphoid cell fate determination
(MAML1), erythroid development (GATA1), liver development
(HNF4A), hair follicle differentiation (HOXC13), kidney cell
differentiation (PAX2), limb development (SP8), hematopoietic
stem cell differentiation (EGR1) (Min et al., 2008), and
cardiovascular development (HEYL), were downregulated.
RA Treatment Regulated Neural Specific
Epigenetic Modifiers
Modification of neural development genes at the DNA level
plays an important role in neural induction (Yao and Jin, 2014).
We analyzed the effect of RA treatment on the expression
pattern of genes that are involved in epigenetic regulation during
neural induction (T7 vs. D7). We found that several genes of
histone methyltransferases were both up- and downregulated
(Figure 2A). Other than EED, a lysine-specific methyltransferase
(PRMT6), and an arginine-specific methyltransferase (KMT2C)
was upregulated. On the other hand, lysine-dependent three
other methyltransferases, namely PRDM2 and 7 and SETD3
were downregulated. Both activating and repressing of histone
methylation marks is necessary for the rapid activation of genes
during differentiation. Similarly, we found lysine (K)-specific
histone demethylase KDM2B was upregulated, whereas KDM5A
was downregulated. Most interestingly, we found genes of HDAC
complex were downregulated (HDAC1, HDAC4, and SIRT6). It
was reported that transcriptional repression mediated by EED
involves histone deacetylation (van der Vlag and Otte, 1999).
HDACs are involved in the transition from deep layer neuron
to upper layer neuron and oligodendrocyte differentiation.
However, there was no change in the gene expression of DNA
methyltransferases. Usually, DNA methylation takes place from
mid-stage to late stage of neuronal differentiation. We assume
that as we collected the sample on the 7th day of culture, it
was too early to detect any DNA methylation activity directly
(Namihira et al., 2008; Murao et al., 2016).
RA Treatment Regulated Neural Specific
Epithelial-Mesenchymal Transition
Epithelial-Mesenchymal Transition is a common phenomenon
during embryonic development, however, is less explained
during neural induction. One of the significantly enriched
hallmark gene sets by the DEGs between T7 and D0 is
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EMT (number of DEGs = 58, p = 1.01 e−24, Table 1).
The previous study reported that formation of neuroectoderm
from hESCs involves genes of extracellular matrix components
(Wang et al., 2012). GO analysis of DEGs between T7 and
D7 revealed that significantly enriched cellular components by
downregulated genes are an integral component of the plasma
membrane, extracellular region, cell surface, and collagen trimer.
Significantly enriched cellular components by upregulated genes
are intracellular organelle and protein complex (Figure 2B).
A similar pattern of gene expression is observed during the early
stage of neuronal differentiation. We found downregulation of
genes from CADHERIN family (CDH6, CDH16, and CDHR5),
COLLAGEN family (COL11A1, COL13A1, COL14A1, COL4A1,
COL4A2, and COL9A1). Moreover, genes associated with tight
junction (CLDN18 and EPB41L5), desmosome (KAZN), cell
surface receptor (CD74, CSPG4, and DCSTAMP), cell polarity
(ARHGAP24), and vesicle transport (FYCO1 and SPIRE 1) were
consistently downregulated (Supplementary Table 1), indicating
potential role of RA treatment in EMT in neural induction
(Pankratz et al., 2007; Park et al., 2012).
RA Treatment Regulated Several
Extracellular Signaling Pathways of
Neural Induction
Several extracellular signaling pathways are well established in a
number of proposed models of neural induction. We examined
the expression profile of genes related to WNT, TGF-β, and BMP
signaling pathways (Doe, 2008). When compared between T7 and
D7 hAECs, we found that several genes of the canonical WNT
pathway (WNT/β catenin) were downregulated, such as BTRC,
CCNY, FZD5, RSPO1, RSPO4, SIX3, WISP3, and WNT5B. On the
other hand, a positive effector of the non-canonical WNT (WNT/
calcium) signaling pathway NLK was upregulated. BMP/TGF-
β signaling pathway related genes, like ACVRL1, ASPN, CHRD,
and SLC39A5 were downregulated. BMP8A, BMP8B, BMPER,
and TGF-β2 were also downregulated. On the other hand, the
major intracellular BMP signaling pathway component SMAD 5
was upregulated (Leung et al., 2013; Huang et al., 2016).
RA Treatment Significantly Inhibited
Notch Signaling Pathway
Notch is considered as a molecular switch in NSCs (Zhou et al.,
2010; Imayoshi and Kageyama, 2011). Loss of Notch signaling in
NSC leads to increased cell cycle exit and decreased progenitor
pool. When compared between T7 and D0 hAECs, several genes
associated with cell cycle and notch signaling were significantly
upregulated (Table 1 and Supplementary Table 1). However,
when compared with T7 and D7 hAECs, we found that RA
treatment could significantly downregulate several genes related
to the Notch pathway indicating that RA treatment could lead
to cell cycle exit and decreased progenitor pool. Notch receptor
(NOTCH2), transmembrane ligand of Notch receptors (DLL1
and DLL3), a positive regulator of Notch (DTX1), a downstream
effector of Notch signaling (HEYL), transcriptional coactivator
for NOTCH (MAML1 and SBNO2), a downstream target of
Notch signaling pathway (PKMYT1) were downregulated.
Furthermore, RA might also work on hAECs through
downregulating neuroactive ligand-receptor interaction
pathways, Ras signaling pathway, the cAMP signaling pathway,
and AMPK signaling pathway (Figure 2E). Ras signaling
pathway is an upstream pathway for MAPK, Rap 1 pathway.
Similarly, cAMP is upstream of the Hedgehog pathway. All of
these pathways are known to be regulated at different stages of
neuronal differentiation and are balancing between self-renewal
and differentiation (Doe, 2008).
RA Treatment Significantly Enriched
Several Neurological and Psychological
Diseases
We used the functional annotation tool of DAVID for
annotating genome-wide data with disease associations using
the GAD (Osborne et al., 2009). Several neurological and
psychological diseases were significantly enriched, particularly
by the downregulated genes, such as Schizophrenia, obsessive-
compulsive disorder, migraine with aura, alcohol consumption,
bulimia, attention deficit disorder, autism, and tobacco use
disorder (Figure 2F). Moreover, major depression, mood
disorders, depression, and suicidal tendency related genes
were also regulated.
DISCUSSION
Placenta-derived hAECs is gaining interest in the field of
regenerative medicine to overcome the current challenges of
existing cell-based therapies, such as cell resources, invasive
extraction procedures, immunological rejection, tumorigenesis
and ethical challenges (Miki, 2011). Previous studies reported
that cultured human amnion cells were able to express markers
characteristic of NSCs (nestin, Musashi-1, and polysialylated
neural adhesion molecule), neural cells (TH, AchT, NeuN,
MAP-2, and myelin basic protein), astrocytes (GFAP), and
oligodendrocytes under optimal differentiation condition (Pan
et al., 2006). However, there is no study on the effect of natural
compounds on hAECs differentiation. In the present study,
we aimed to evaluate microarray gene expression profiling of
RA-treated 3D spheroids of hAECs to explore its neuronal
differentiation-inducing effect and to provide a foundation for
further examination of molecular mechanisms. Altogether, our
profiling analysis suggests a potential role of RA in neural
induction and neuronal differentiation of hAECs (Figure 3).
Our findings suggest that cultured hAECs are able to
express stem cell markers, while RA treatment could direct the
differentiation of hAECs toward ectodermal lineage. Although
the mechanisms of neuronal cell fate determination are
not fully elucidated yet, it is apparent that cell-intrinsic
programs, including epigenetic regulations as well as TFs and
extracellular cues, are involved in this fate specification of
stem cells (Schuldiner et al., 2001). Neuronal differentiation is
facilitated through promoting proneural genes of neurogenesis
and inhibitory mechanisms that maintain self-renewal and
proliferation. Remodeling of chromatin structure through
histone modification is an important mechanism of modulating
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FIGURE 3 | Summary of the Effect of RA in hAECs differentiation.
gene expression (Murao et al., 2016). We found that RA
treatment could regulate histone modification by simultaneously
up and downregulating several histone methyltransferases and
histone demethylases. Both the activation and repression
of histone methylation marks are necessary for the rapid
activation of genes during differentiation. Among the histone
methyltransferases that were differentially expressed in the
treatment hAECs, Eed is the most important. Eed is an
active component of PRC2 and was highly expressed in the
treated cells. The epigenetic PRC1 promotes proliferation and
self-renewal of NSCs, whereas PRC2-mediated gene silencing
enhances NSC activation and neurogenesis through histone
methylation (van der Vlag and Otte, 1999). Eed suppresses the
expression of Gata6 and thereby increases p21 protein level.
Gata6 is essential for primitive gut and heart development.
On the other hand, increased p21 leads to inhibition of NSC
proliferation and self-renewal, and activation of neurogenesis
(Sun et al., 2018). Thus, RA may regulate neuroectodermal
lineage progression via epigenetic polycomb protein Eed. PRCs
together with histone acetylation also affect layer formation of
the cortex. Inhibition of HDACs activity decreases the production
of deep layer neurons and increases upper layer neurons, and
promotes oligodendrocyte production (Namihira et al., 2008).
RA treatment downregulated the expressions of HDAC1 and
HDAC4. Furthermore, we found upregulation of BCOR in the
RA-treated hAECS. BCoR can function as a corepressor when
tethered to DNA and, when overexpressed, can potentiate BCL-
6 repression (Huynh et al., 2000). Specific class I and II HDACs
interact with BCoR, suggesting that BCoR may functionally link
these two classes of HDACs.
Neuronal differentiation is also regulated by many neural
specific bHLH family transcriptional activators and repressors,
and the balance of activity between these factors is important
for the differentiation process. Helt is a member of bHLH-O
transcriptional repressors and contains the characteristic Orange
domains. Helt is mainly expressed in the neural progenitors and is
down-regulated before neuronal differentiation (Nakatani et al.,
2004). Tcf12 (also known as Heb) is a member of the E-box
protein family, a subfamily of bHLH protein family members.
It plays a critical role during embryonic and adult neurogenesis
(Uittenbogaard and Chiaramello, 2002; Mesman and Smidt,
2017). Tcf12 is involved in the control of proliferating stem cells
and progenitor cells and early cell fate determination depending
on the timing and location of TCF12 expression. In this study, we
found upregulation of TCF12 expression and downregulation of
HELT on the 7th day of RA treatment of hAECs.
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Epithelial-mesenchymal transition is a common phenomenon
during embryonic development. However, EMT during neural
induction is not well characterized yet. GO analysis of DEGs
revealed highly enriched molecular functions of extracellular
matrix component, collagen trimers as well as enriched cellular
components of the plasma membrane, cell surface, protein
binding, and proteinaceous extracellular matrix (Wang et al.,
2012). Together, our GSEA and gene annotation analysis suggests
a potential role of RA in EMT and promoting neural induction
(Figure 2B and Table 1).
Signaling pathway analysis allows us to understand the
molecular basis of biological events that take place during stem
cell differentiation. We found that several extracellular pathways
were regulated on the 7th day of RA treatment. RA treatment
downregulated the expression of several genes related to the
canonical WNT pathway, and BMP/TGF-β pathway, whereas
upregulated non-canonical effector NLK. It has been reported
that inhibition of the canonical WNT pathway promotes ESCs
differentiation toward ectodermal fate, and activation of the
non-canonical WNT pathway enhances neural fate by limiting
epidermal choice (Huang et al., 2016). We also found the
decreased activity of BMP/TGF-β signaling indicating neural
differentiation took place (Doe, 2008). However, most SMAD
genes were not changed probably because of their association
with EMT during neural induction.
Furthermore, we found that RA treatment could significantly
inhibit the Notch pathway. Notch signal pathway has multiple
critical roles in the regulation of NSC differentiation and
is considered as a molecular switch between neurogenic
to gliogenic differentiation of NSCs. Previous evidence
suggests that Notch inhibition could promote neuronal
commitment and neurogenesis, decreased progenitor pool,
and inhibit glial fate differentiation (Zhou et al., 2010;
Imayoshi and Kageyama, 2011).
Currently, we are using several semi-biological and synthetic
stimulants in neuronal differentiation medium, like neurobasal
medium, neural cell supplement N2, non-essential amino
acid, BDNF, glial cell line-derived neurotrophic factors, cAMP,
ascorbic acid, and laminin. We also use inhibitors of GSK3,
TGF-β, and AMPK for neural induction medium. Continuous
replacement of this medium makes the whole procedure highly
expensive. Therefore, RA would have potential as a cost-effective,
easily available alternative stimulant of neuronal differentiation.
Additionally, previous studies showed that transplantation
of hAECs into the brain of mice with Parkinson’s disease
could significantly increase both the duration of rotation
and the number of spontaneous movements (Kong et al.,
2008). This suggests that the transplanted hAECs were able to
promote endogenous neurogenesis in the SVZ and enhance
preservation of the nigrostriatal system. We found that RA
treatment could significantly enrich several neurological and
psychological diseases, suggesting regulation of genes related to
brain diseases. Therefore, RA-induced hAECs may have potential
as a new therapeutic approach for several neurodegenerative
and psychiatric disorders, including Alzheimer’s disease,
Parkinson’s disease, spinal cord injuries, and Huntington’s
disease. Furthermore, the differentiation potential of hAECs
toward a specific direction using a natural compound unveils
the great potential of hAECs as a novel tool for drug screening.
However, further in-depth investigations on time and dose-
dependent effects of RA treatment on morphology, physiology,
and gene expression pattern of hAECs are warranted to confirm
its neuronal differentiation potential.
DATA AVAILABILITY
All data generated or analyzed during this study are
included in this published article and its Supplementary
Files. Microarray data are deposited in the Gene Expression
Omnibus (GEO) under Accession Number: GSE133277
(https://www.ncbi.nlm.nih.gov/geo/info/linking.html).
AUTHOR CONTRIBUTIONS
FF investigated the study, responsible for data curation, carried
out the formal analysis, visualized the data, and wrote the original
draft of the manuscript. KS investigated the study, and carried out
the methodology and data validation. YU investigated the study
and carried out the formal analysis. NO and HI conceptualized
the study, involved in funding acquisition, and carried out the
project administration. NO, Y-WZ, and HI were responsible
for the resources, supervised the study, and wrote, reviewed,
and edited the manuscript. All authors made the substantial
contributions to the manuscript and approved its final version.
FUNDING
This work was supported by the Japan Science and Technology
Agency (JST), Japan International Cooperation Agency (JICA)
(SATREPS), and JST-Center of Innovation (COI) project.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fnins.
2019.00779/full#supplementary-material
REFERENCES
Alagawany, M., El-Hack, M. E. A., Farag, M. R., Gopi, M., Karthik, K., Malik, Y. S.,
et al. (2017). Rosmarinic acid: modes of action, medicinal values and health
benefits. Anim. Health Res. Rev. 18, 167–176. doi: 10.1017/S1466252317000081
Arai, M. A., Koryudzu, K., Koyano, T., Kowithayakorn, T., and Ishibashi, M.
(2013). Naturally occurring Ngn2 promoter activators from butea superba. Mol.
BioSyst. 9, 2489–2497. doi: 10.1039/c3mb70083f
Ben-Porath, I., Thomson, M. W., Carey, V. J., Ge, R., Bell, G. W., Regev, A.,
et al. (2008). An embryonic stem cell-like gene expression signature in poorly
Frontiers in Neuroscience | www.frontiersin.org 9 July 2019 | Volume 13 | Article 779
fnins-13-00779 July 22, 2019 Time: 17:19 # 10
Ferdousi et al. Neuronal Differentiation of hAECs by Rosmarinic Acid
differentiated aggressive human tumors. Nat. Genet. 40, 499–507. doi: 10.1038/
ng.127
De Coppi, P., Bartsch, G., Siddiqui, M. M. jr., Xu, T., Santos, C. C., Perin, L., et al.
(2007). I∗solation of amniotic stem cell lines with potential for therapy. Nat.
Biotechnol. 25:100.
Doe, C. Q. (2008). Neural stem cells: balancing self-renewal with differentiation.
Development 135, 1575–1587. doi: 10.1242/dev.014977
Huang, C. T.-L., Tao, Y., Lu, J., Jones, J. R., Fowler, L., Weick, J. P., et al.
(2016). Time-course gene expression profiling reveals a novel role of non-
canonical WNT signaling during neural induction. Sci. Rep. 6:32600. doi: 10.
1038/srep32600
Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009). Systematic and
integrative analysis of large gene lists using DAVID bioinformatics resources.
Nat. Protoc. 4, 44–57. doi: 10.1038/nprot.2008.211
Huynh, K. D., Fischle, W., Verdin, E., and Bardwell, V. J. (2000). BCoR, a novel
corepressor involved in BCL-6 repression. Genes Dev. 14, 1810–1823.
Imayoshi, I., and Kageyama, R. (2011). The role of notch signaling in adult
neurogenesis. Mol. Neurobiol. 44, 7–12. doi: 10.1007/s12035-011-8186-0
Kondo, S., El Omri, A., Han, J., and Isoda, H. (2015). Antidepressant-like effects of
rosmarinic acid through mitogen-activated protein kinase phosphatase-1 and
brain-derived neurotrophic factor modulation. J. Funct. Foods 14, 758–766.
doi: 10.1016/j.jff.2015.03.001
Kong, X.-Y., Cai, Z., Pan, L., Zhang, L., Shu, J., Dong, Y.-L., et al. (2008).
Transplantation of human amniotic cells exerts neuroprotection in MPTP-
induced parkinson disease mice. Brain Res. 1205, 108–115. doi: 10.1016/j.
brainres.2008.02.040
Kongros, B., Bunyaratvej, A., Viyoch, J., and Sila-asna, M. (2012). The effects
of seed extract of mucuna gigantea on the expression of neural markers in
mesenchymal stem cells. J. Med. Plants Res. 6, 1297–1303.
Leung, A. W., Morest, D. K., and Li, J. Y. H. (2013). Differential BMP signaling
controls formation and differentiation of multipotent preplacodal ectoderm
progenitors from human embryonic stem cells. Dev. Biol. 379, 208–220. doi:
10.1016/j.ydbio.2013.04.023
Li, M., Choi, S. T., Tsang, K. S., Shaw, P. C., and Lau, K. F. (2012). DNA microarray
expression analysis of baicalin-induced differentiation of c17. 2 neural stem
cells. ChemBioChem 13, 1286–1290. doi: 10.1002/cbic.201200145
Ma, L., Feng, X.-Y., Cui, B.-L., Law, F., Jiang, X.-W., Yang, L.-Y., et al.
(2005). Human umbilical cord wharton’s jelly-derived mesenchymal stem cells
differentiation into nerve-like cells. Chin. Med. J. 118, 1987–1993.
Marion, N. W., and Mao, J. J. (2006). Mesenchymal stem cells and tissue
engineering. Methods Enzymol. 420, 339–361.
McDonald, C., Siatskas, C., and Bernard, C. C. A. (2011). The emergence of amnion
epithelial stem cells for the treatment of multiple sclerosis. Inflamm. Regen. 31,
256–271. doi: 10.2492/inflammregen.31.256
Mesman, S., and Smidt, M. P. (2017). Tcf12 is involved in early cell-fate
determination and subset specification of midbrain dopamine neurons. Front.
Mol. Neurosci. 10:353. doi: 10.3389/fnmol.2017.00353
Miki, T. (2011). Amnion-derived stem cells: in quest of clinical applications. Stem
Cell Res. Ther. 2:25. doi: 10.1186/scrt66
Miki, T., Lehmann, T., Cai, H., Stolz, D. B., and Strom, S. C. (2005). Stem cell
characteristics of amniotic epithelial cells. Stem Cells 23, 1549–1559. doi: 10.
1634/stemcells.2004-0357
Miki, T., and Strom, S. C. (2006). Amnion-derived pluripotent/multipotent stem
cells. Stem Cell Rev. 2, 133–141. doi: 10.1007/s12015-006-0020-0
Min, I. M., Pietramaggiori, G., Kim, F. S., Passegué, E., Stevenson, K. E.,
and Wagers, A. J. (2008). The transcription factor EGR1 controls both the
proliferation and localization of hematopoietic stem cells. Cell Stem Cell 2,
380–391. doi: 10.1016/j.stem.2008.01.015
Murao, N., Noguchi, H., and Nakashima, K. (2016). Epigenetic regulation of neural
stem cell property from embryo to adult. Neuroepigenetics 5, 1–10. doi: 10.1016/
j.nepig.2016.01.001
Nakatani, T., Mizuhara, E., Minaki, Y., Sakamoto, Y., and Ono, Y. (2004).
Helt, a novel basic-helix-loop-helix transcriptional repressor expressed in the
developing central nervous system. J. Biol. Chem. 279, 16356–16367. doi:
10.1074/jbc.m311740200
Namihira, M., Kohyama, J., Abematsu, M., and Nakashima, K. (2008). Epigenetic
mechanisms regulating fate specification of neural stem cells. Philos. Trans. R.
Soc. Lond. B Biol. Sci. 363, 2099–2109. doi: 10.1098/rstb.2008.2262
Niknejad, H., Peirovi, H., Ahmadiani, A., Ghanavi, J., and Jorjani, M. (2010).
Differentiation factors that influence neuronal markers expression in vitro from
human amniotic epithelial cells. Eur. Cell Mater 19, 22–29. doi: 10.22203/ecm.
v019a03
Osborne, J. D., Flatow, J., Holko, M., Lin, S. M., Kibbe, W. A., Zhu, L. J., et al.
(2009). Annotating the human genome with disease ontology. BMC Genomics
10:S6. doi: 10.1186/1471-2164-10-S1-S6
Pan, L., Shu, J., and Cai, Z. (2006). The morphologic study of the characteristics of
neurobiology of the amniotic membrane. Chin. J. Rehabil. Med. 21, 46–49.
Pankratz, M. T., Li, X. J., LaVaute, T. M., Lyons, E. A., Chen, X., and Zhang,
S. C. (2007). Directed neural differentiation of human embryonic stem cells via
an obligated primitive anterior stage. Stem Cells 25, 1511–1520. doi: 10.1634/
stemcells.2006-0707
Park, J. H., Choi, M. R., Park, K. S., Kim, S. H., Jung, K. H., and Chai, Y. G.
(2012). The characterization of gene expression during mouse neural stem cell
differentiation in vitro. Neurosci. Lett. 506, 50–54. doi: 10.1016/j.neulet.2011.
10.046
Raghavan, R. N., Vignesh, G., Kumar, B. S., Selvaraj, R., and Dare, B. J. (2015).
Phytochemicals: do they hold the future in stem cell differentiation. Int. J. Res.
Pharma 6, 379–381. doi: 10.7897/2277-4343.06374
Sakuragawa, N., Thangavel, R., Mizuguchi, M., Hirasawa, M., and Kamo, I. (1996).
Expression of markers for both neuronal and glial cells in human amniotic
epithelial cells. Neurosci. Lett. 209, 9–12. doi: 10.1016/0304-3940(96)12599-4
Sasaki, K., El Omri, A., Kondo, S., Han, J., and Isoda, H. (2013). Rosmarinus
officinalis polyphenols produce anti-depressant like effect through
monoaminergic and cholinergic functions modulation. Behav. Brain Res.
238, 86–94. doi: 10.1016/j.bbr.2012.10.010
Schuldiner, M., Eiges, R., Eden, A., Yanuka, O., Itskovitz-Eldor, J., Goldstein, R. S.,
et al. (2001). Induced neuronal differentiation of human embryonic stem cells.
Brain Res. 913, 201–205.
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L.,
Gillette, M. A., et al. (2005). Gene set enrichment analysis: a knowledge-based
approach for interpreting genome-wide expression profiles. Proc. Nat. Acad. Sci.
102:15545. doi: 10.1073/pnas.0506580102
Sun, B., Chang, E., Gerhartl, A., and Szele, F. G. (2018). Polycomb protein eed is
required for neurogenesis and cortical injury activation in the subventricular
zone. Cereb. Cortex 28, 1369–1382. doi: 10.1093/cercor/bhx289
Udalamaththa, V. L., Jayasinghe, C. D., and Udagama, P. V. (2016). Potential role of
herbal remedies in stem cell therapy: proliferation and differentiation of human
mesenchymal stromal cells. Stem Cell Res. Ther. 7:110. doi: 10.1186/s13287-
016-0366-4
Uittenbogaard, M., and Chiaramello, A. (2002). Expression of the bHLH
transcription factor Tcf12 (ME1) gene is linked to the expansion of precursor
cell populations during neurogenesis. Gene Exp. Patterns 1, 115–121. doi:
10.1016/s1567-133x(01)00022-9
van der Vlag, J., and Otte, A. P. (1999). Transcriptional repression mediated by
the human polycomb-group protein EED involves histone deacetylation. Nat.
Genetics 23:474. doi: 10.1038/70602
Villareal, M. O., Ikeya, A., Sasaki, K., Arfa, A. B., Neffati, M., and Isoda, H. (2017).
Anti-stress and neuronal cell differentiation induction effects of Rosmarinus
officinalis L. essential oil. BMC Comp. Altern. Med. 17:549. doi: 10.1186/s12906-
017-2060-1
Wang, K., Wang, H., Wang, J., Xie, Y., Chen, J., Yan, H., et al. (2012).
System approaches reveal the molecular networks involved in neural
stem cell differentiation. Protein Cell 3, 213–224. doi: 10.1007/s13238-012-
0014-4
Yao, B., and Jin, P. (2014). Unlocking epigenetic codes in neurogenesis. Genes Dev.
28, 1253–1271. doi: 10.1101/gad.241547.114
Zhou, Z. D., Kumari, U., Xiao, Z. C., and Tan, E. K. (2010). Notch as a molecular
switch in neural stem cells. IUBMB Life 62, 618–623. doi: 10.1002/iub.362
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Ferdousi, Sasaki, Uchida, Ohkohchi, Zheng and Isoda. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner(s) are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Neuroscience | www.frontiersin.org 10 July 2019 | Volume 13 | Article 779
